BGIG Bahl & Gaynor Income Growth ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| JNJ | 6.23% |
| AVGO | 4.62% |
| LLY | 3.67% |
| MSFT | 3.65% |
| TRV | 3.63% |
| WMB | 3.57% |
| ABBV | 3.33% |
| NEE | 3.22% |
| XOM | 3.07% |
| CVX | 3.04% |
ETF Analysis
Fund Overview
Bahl & Gaynor Income Growth ETF (BGIG) currently reports 49 stock positions (subject to change), placing it in the selectively diversified range by holdings breadth. The top line-up is JNJ (6.23%), AVGO (4.62%), LLY (3.67%), with JNJ as the largest single weight at 6.23%. Together, the top three holdings account for 14.52%, which points to a relatively flat weight distribution where no single cluster of names dominates outcomes. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.
Profitability & Capital Efficiency
Assessing the quality of returns on invested capital, ROIC is 17.13%, WACC is 7.24%, and the economic spread is 9.88%. On balance, the economic spread is thin but positive — the portfolio's businesses are clearing the hurdle, though without significant headroom. Supporting metrics show ROE at 29.75% and ROA at 8.16%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.
Valuation
The market currently prices the portfolio at trailing P/E of 23.53, forward P/E of 18.87, PEG of 2.50. The gap between P/E and forward P/E is small, suggesting the valuation is not contingent on a near-term earnings step-change. The PEG ratio is consistent with a portfolio that is reasonably valued on a growth basis — not cheap, but not obviously expensive either. The current ratio of 1.52 is in an acceptable range, reflecting reasonable short-term financial health. Valuation and liquidity together frame a portfolio where the price paid today is a reasonable bet on earnings delivery — but not a margin-of-safety purchase at current levels.
Margins & Cash Generation
Looking at margins from gross to free cash flow, gross margin sits at 51.30%, operating margin at 28.50%, and free cash flow margin at 17.84%. Gross margins are constructive — not exceptional, but indicative of businesses with reasonable unit economics. At this level, operating margins reflect businesses that are scaling with discipline without dramatic cost pressure. The portfolio's cash conversion is solid — a sign that operating profits are translating into real liquidity at the fund level. All three margin layers are constructive, pointing to a portfolio where quality of earnings is high and cash generation is reliable.
Growth & Forward Outlook
Projected 12-month EPS growth of 24.7% adds a powerful forward signal — analyst consensus expects earnings to accelerate materially, which, if delivered, could make current multiples look increasingly modest. Zooming out from the valuation discussion, TTM revenue growth of 12.33% pointing to stable operational progress without outsized acceleration, while the estimated 12-month price change of 13.05%, where target prices point to mid-range appreciation potential from current levels. Anchoring to reported revenues provides discipline; analyst price targets add context about how the market currently values that operating reality. The path to realizing analyst-implied returns runs through revenue execution, margin stability, and a macro environment that doesn't undermine either. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyTaken together, the metrics present a favorable setup — not without risk, but with enough quality and momentum to support a positive view.
The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.